Zhang et al. (Zhang et al., 2019) suggest that tumor-associated gene mutations, including EGFR, KRAS, ALK, HER2, BRAF, ROS1, RET, and others, could predict the emergence of primary tumors by indicating ctDNA gene changes, thus emphasizing the potential of the ctDNA testing approach. This evidence concerns the gene EGFR and neoplasm.